| Michael Hood Chamales, MD | |
|
15010 Slide Dr, Lubbock, TX 79424 | |
| (806) 872-4179 | |
| Not Available |
| Full Name | Michael Hood Chamales |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 15010 Slide Dr, Lubbock, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285642603 | NPI | - | NPPES |
| 1401648-03 | Medicaid | TX | |
| 93-0724316 | Other | TX | TAX ID |
| Entity Name | Seminole Hospital District Of Gaines County Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821025990 PECOS PAC ID: 2668382516 Enrollment ID: O20040428000104 |
News Archive
In a short correspondence paper recently uploaded to the Lancet by Ramanathan, Muthukumar et al. (May 19th, 2021) the affinity of labeled SARS-CoV-2 spike receptor-binding domain proteins sourced from each of these two variants of concern towards human angiotensin-converting enzyme 2 (ACE2) recombinant proteins is investigated using microscale thermophoresis, confirming the enhanced affinity towards the receptor observed in other studies.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
A pilot study into the use of near patient diagnostics in general practice, to help GPs and nurse practitioners prescribe antibiotics for chest infections more precisely, has won a national Public Health England Award.
The first analysis of the carbon footprint of surgical suites at three hospitals in the UK, Canada and the USA highlights that the choice of anesthetic gases used in surgery can be a major contributor to greenhouse gas emissions from operating theaters.
› Verified 9 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
In a short correspondence paper recently uploaded to the Lancet by Ramanathan, Muthukumar et al. (May 19th, 2021) the affinity of labeled SARS-CoV-2 spike receptor-binding domain proteins sourced from each of these two variants of concern towards human angiotensin-converting enzyme 2 (ACE2) recombinant proteins is investigated using microscale thermophoresis, confirming the enhanced affinity towards the receptor observed in other studies.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
A pilot study into the use of near patient diagnostics in general practice, to help GPs and nurse practitioners prescribe antibiotics for chest infections more precisely, has won a national Public Health England Award.
The first analysis of the carbon footprint of surgical suites at three hospitals in the UK, Canada and the USA highlights that the choice of anesthetic gases used in surgery can be a major contributor to greenhouse gas emissions from operating theaters.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Hood Chamales, MD 15010 Fm 1730, Lubbock, TX 79424-6635 Ph: (806) 863-4206 | Michael Hood Chamales, MD 15010 Slide Dr, Lubbock, TX 79424 Ph: (806) 872-4179 |
News Archive
In a short correspondence paper recently uploaded to the Lancet by Ramanathan, Muthukumar et al. (May 19th, 2021) the affinity of labeled SARS-CoV-2 spike receptor-binding domain proteins sourced from each of these two variants of concern towards human angiotensin-converting enzyme 2 (ACE2) recombinant proteins is investigated using microscale thermophoresis, confirming the enhanced affinity towards the receptor observed in other studies.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
A pilot study into the use of near patient diagnostics in general practice, to help GPs and nurse practitioners prescribe antibiotics for chest infections more precisely, has won a national Public Health England Award.
The first analysis of the carbon footprint of surgical suites at three hospitals in the UK, Canada and the USA highlights that the choice of anesthetic gases used in surgery can be a major contributor to greenhouse gas emissions from operating theaters.
› Verified 9 days ago
Charles Hudson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Phone: 972-829-6613 Fax: 800-611-5029 | |
Dr. Ronald L. Cook, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 1c143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |